Focus on increasing throughput of processes has favoured poorer models with lower chances of success
The search for new medicines is becoming unsustainably expensive despite huge technological advances because researchers are using the wrong methods, experts say.
They say drug discovery should focus on ‘validity’ – how well the results of experiments predict results in sick people. Instead, it has focused on methods that are easy to industrialize or methods that are academically fashionable.
In a report published in the journal PLOS ONE, Jack Scannell, from Oxford University’s Centre for the Advancement of Sustainable Medical Innovation, and consultant Jim Bosley approach drug discovery using mathematical tools that are used by economists to study decision making. They show that the chance of discovering an effective drug is surprisingly sensitive to the validity of the experimental methods. Small changes in validity can have a bigger effect than running 10 or even 100 times more experiments.
They argue that productivity has declined because the most predictive methods lead to the discovery of good drugs, and research in those areas stops (e.g., stomach ulcers). This leaves scientists working on as-yet-untreated diseases using less predictive discovery methods (e.g., Alzheimer’s). They also suggest that changing industrial and scientific fashions have contributed to the problem.
The result: Methods have become less predictive over time, worse decisions have been made, and the cost of discovery has gone up.
Drug approvals have increased since 2012. The researchers say that this is likely down to the rising use of genetic information which improves the validity of the methods to discover treatments for rare diseases, though less so for common diseases.
Dr Jack Scannell said: ‘There is a nasty puzzle at the heart of modern biomedical research. On one hand, the technologies that people think are important have become hundreds, thousands, or even billions of times cheaper. On the other hand, it costs nearly 100 times more to bring a drug to market today than it did in 1950. New drugs can be very expensive, yet the industry is closing labs and firing scientists. Our work goes some way towards explaining the puzzle. Governments, companies, and charities should focus on identifying and funding predictive methods, even if they don’t match current scientific fashion.’
The Latest on: Drug development crisis
via Google News
The Latest on: Drug development crisis
- Where To Find The Real Crisis In Clinical Research? Follow The Moneyon September 19, 2022 at 6:50 am
"How can the clinics and hospitals who treat patients with new drug candidates retain the nurses and study coordinators who oversee the treatment of patients who enroll into clinical trials?" ...
- Concerns as Africa struggles to isolate, contain hidden drug-resistant pathogenson September 19, 2022 at 5:45 am
Resistance to drugs is a grave threat to achievement of universal health coverage and can lead to catastrophic health outcomes.
- DEA training agencies to investigate overdose deaths in hopes of reigning in crisison September 16, 2022 at 9:24 pm
DEA Special Agent in Charge of the St. Louis Division Michael Davis says there were 1,030 overdose deaths in the St. Louis Metro and fentanyl played a massive contributor in those deaths. A News 4 ...
- The meth crisis is worse than ever, but new treatments might be around the corneron September 16, 2022 at 1:35 am
Despite the skyrocketing use of meth, a stimulant particularly common in the western U.S., there’s no medication currently approved to treat meth overdose or aid in long-term recovery. Doctors who ...
- Column: How to solve today’s drug crisison September 15, 2022 at 2:30 am
I am saddened to continually read The Times-Dispatch and media articles indicating the increasing supply and demand for both legal and illegal drug substances. Three articles are in front of me as I ...
- I Was an 18-Year-Old Addict Carrying a Drug Dealer’s Babyon September 14, 2022 at 11:33 am
Having witnessed the horrors of drug and alcohol abuse firsthand, I entered junior high school vowing never to take drugs—at least until a fellow eighth-grader kept badgering me to try a marijuana ...
- Securing drug supply chain is importanton September 14, 2022 at 9:00 am
However, concerns rose over a possible crisis in the drug supply chain after COVID-19 disrupted global logistics chains. Last year, the US released its “100-day reviews” of four critical supply chains ...
- New water crisis, drag show threats, nurses strike: News from around our 50 stateson September 13, 2022 at 9:23 am
Arson suspected in fire that destroyed historic South LA church, ‘Baby Shark’ plaintiff found dead in Oklahoma cell, and more ...
- Massachusetts Institute of Technology: Analyzing the potential of AlphaFold in drug discoveryon September 10, 2022 at 12:39 am
Over the past few decades, very few new antibiotics have been developed, largely because current methods for screening potential drugs are prohibitively expensive and time-consuming. One promising new ...
- Advances in modeling molecular interactions needed to better harness AlphaFold for drug discoveryon September 6, 2022 at 5:14 pm
Over the past few decades, very few new antibiotics have been developed, largely because current methods for screening potential drugs are prohibitively expensive and time-consuming.
via Bing News